Biotech License » Company

Which is the best way of getting job in USA (biotech company)?

admin — Sun, 18 Apr 2010 10:59:14 +0000

I have been working as a In charge of liaison office of the of USA biotechnology company in India since March 2007. I have also worked as Lab Manager about 5 years in Biotechnology lab at India’s top University Campus.

how do you become a CEO of a biotech company??

admin — Sat, 17 Apr 2010 11:41:59 +0000

Like if you want to reach the top of your career in genetic engineering how would you go along it to become a CEO of a biotech company?

What Colleges Are Great If I Want To Go Into A Biotechnology Company As A Researcher?

admin — Fri, 26 Feb 2010 14:50:25 +0000

I live on the West Coast, so preferably colleges/universities on the west coast! Thank you!

What Is The Difference Between Biotech And A Pharmaceutical Company?

admin — Tue, 23 Feb 2010 08:36:45 +0000

Given that the pharmaceutical industry has been around a while, most people have a pretty firm grasp of what drug companies do. They manufacture and market the myriad medications we find both behind and over the pharmacist’s counter.
What then, is biotechnology, which also works to develop new drugs? What is the difference between biotech and traditional drug companies?
Not much anymore, and the lines of distinction will continue to blur, say those in the field.
“It’s a very complicated matrix right now, where it wasn’t in the past,” says Phyllis Gardner, associate professor of medicine at Stanford University and former vice president of Alva Corp., one of the very first biotech companies. “There is no clear line, but there are some distinguishing features.”
Comparing biotech companies to pharmaceutical companies, she says, can be done two ways: as a business model and as a field of research.
Pharmaceutical companies traditionally employed what Ms. Gardner calls “empirical screening” to develop drugs. “They would take natural compounds with a known physiological side effect, like reducing blood pressure, and they would screen for that effect,” she says.
Chris Littlehales, director of communications for Burrill and Co., an investment firm that focuses on the biotech industry, likens pharma to throwing a lot of spaghetti at the wall to see what sticks.
“The traditional way of making a drug was like analytical chemistry,” she says.
For instance, she says, everyone knows that aspirin exists and it reduces fever and aches. But it also causes stomach problems in some people. So you want to make something that has the same benefits, without the side effects.
“If you’re a medicinal chemist you will analyze it and figure out what part of aspirin causes the problem,” Ms. Littlehales says. “So you fool around and take this out and put this in, and you have to keep testing every little variation against the target. Sooner or later you hit on something.”
Biotechnology, on the other hand, is defined by Informagen Inc., an online biotech information resource, as using “genetic engineering” technology in its research. Ms. Gardner says biotech was originally based around molecules, called monoclonal antibodies, which mimicked certain proteins or other molecules to target a specific cell area.
This type of research began around 1972, when Stanford’s Paul Berg and Stanley Cohen, and Herbert Boyer of the University of California at San Francisco were the first to successfully splice genes from viruses to create molecules of recombinant DNA.
Ms. Littlehales says genetic engineering was touted to be the cure for just about every disease. Subsequent years saw an explosion of biotech companies, hoping to capitalize on the technology.
“It used to be the premise that biotech companies were young, emerging companies that developed products in the biological areas of DNA, RNA, etc. They were young entrepreneurial companies,” says Scott Morrison, who leads the U.S. Life Sciences division at Ernst & Young.

What Does Anyone Out There Think Of The Biotech Company Known As Viragen?

admin — Sun, 21 Feb 2010 09:11:30 +0000

Hello Sweetie-Pi,
Having a bit of knowledge in stocks and various investment vehicles, may I suggest a pass on this one. Please take a quick look at the two charts below, one for Viragen and the other for it’s parent company. Pretty dismal if you ask me, which you did. If only because of the past performance alone as a indication, I would not buy this companies stock. I mean no disrespect to the company itself or it’s management but one should have expected much better stock performance given the products they have or are working on. Also the fact that their product(s) are not approved here in the states leaves me dubious. But even then with all my skepticism there is always the possibility that they could indeed have a major breakthrough and their stock could take off. But I don’t see it. Please do your own investigation on this one. Check their SEC filings to start. Good luck & Booya Tooya